Zimmer Biomet Holdings (ZBH) : Fridays money flow data in Zimmer Biomet Holdings (ZBH) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $61.95 million, whereas, $38.88 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.59, in favor of the bulls. The total money flow into the stock was $23.07 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $21.84 million. The total value of block trades done on upticks was $27.27 million. The value of bearish trades on downticks was only $5.43 million.The up/down ratio in the block trades was a healthy 5.02 in favor of the bulls, suggesting strong buying in the stock by large traders. Zimmer Biomet Holdings (ZBH) fell $0.81 and traded at $124.48, down -0.65% for the day, over previous days close. On a weekly basis, the shares are -0.75% over the previous weeks close.
Zimmer Biomet Holdings (ZBH) : 15 investment research analysts covering Zimmer Biomet Holdings (ZBH) have an average price target of $129.93 for the near short term. The highest target price given by the Brokerage Firm to the stock is $143 and the lowest target is $105 for the short term. Analysts expect the variance to be within $8.81 of the average price.
Zimmer Biomet Holdings (NYSE:ZBH): On Fridays trading session , Opening price of the stock was $124.79 with an intraday high of $124.92. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $122.68. However, the stock managed to close at $124.48, a loss of 0.65% for the day. On the previous day, the stock had closed at $125.29. The total traded volume of the day was 1,532,798 shares.
In a related news, The Securities and Exchange Commission has divulged that Florin Daniel P, officer (Sr. VP, CFO) of Zimmer Biomet Holdings, Inc., had unloaded 15,000 shares at an average price of $124.98 in a transaction dated on July 8, 2016. The total value of the transaction was worth $1,874,700.
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc. is a musculoskeletal healthcare company. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company manages its operations through three geographic segments: the Americas, comprising principally of the United States and includes other North, Central and South American markets; Europe, comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific, comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers, and directly to dental practices and dental laboratories.